HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate.

AuthorsE Simpson, S G O'Brien, J T Reilly
JournalClinical and laboratory haematology (Clin Lab Haematol) Vol. 28 Issue 3 Pg. 215-6 (Jun 2006) ISSN: 0141-9854 [Print] England
PMID16706941 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Antineoplastic Agents (adverse effects)
  • Benzamides
  • Blast Crisis (drug therapy)
  • Brain Neoplasms (secondary)
  • Fatal Outcome
  • Female
  • Hematopoiesis, Extramedullary (drug effects)
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, pathology)
  • Male
  • Middle Aged
  • Piperazines (adverse effects)
  • Pyrimidines (adverse effects)
  • Remission Induction
  • Skin Neoplasms (secondary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: